Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NATEGLINIDE
- Effect of Pioglitazone on T2DM Patients With COVID-19
- Incretin-based Drugs and Acute Pancreatitis
- Incretin-based Drugs and Pancreatic Cancer
- Incretin-based Drugs and the Risk of Heart Failure
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
- A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions
- Liraglutide Hospital Discharge Trial
- A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients
- Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition
- Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
- Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion
- Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors
- Study of the Durability of Glycemic Control With Nateglinide
- Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
- Prevention of Diabetes and Hypertension
- The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
- Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone
- Combination of Glinides With Premixed Insulin
- Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
- Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?
- A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion
- Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
- Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
- Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications
Clinical trials list
click for details